Advanced search
Publication Cover
Postgraduate Medicine Volume 132, 2020 - Issue 2
Submit an article Journal homepage
3,576
Views
21
CrossRef citations to date
0
Altmetric
Clinical Features - Health Outcomes

Real-world management of hyperkalemia with patiromer among United States Veterans

Csaba P. Kovesdya Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USACorrespondence[email protected]
View further author information
,
Elvira O. Gosmanovab Nephrology Section, Samuel S. Stratton VA Medical Center, Albany, NY, USA;c Division of Nephrology, Department of Medicine, Albany Medical College, Albany, NY, USAView further author information
,
Steven D. Woodsd Managed Care and Health Outcomes, Relypsa, Inc., a Vifor Pharma Group Company, Redwood City, CA, USAView further author information
,
Jeanene J. Foglie Health Economics and Outcomes Research, Relypsa, Inc., a Vifor Pharma Group Company, Redwood City, CA, USAView further author information
,
Christopher G. Rowanf Pharmacoepidemiology, COHRDATA, Santa Monica, CA, USAView further author information
,
Jared L. Hanseng Division of Epidemiology, Salt Lake City VA Medical Center (IDEAS), University of Utah, Salt Lake City, UT, USAView further author information
&
Brian C. Sauerg Division of Epidemiology, Salt Lake City VA Medical Center (IDEAS), University of Utah, Salt Lake City, UT, USAView further author information
 show all
Pages 176-183 | Received 09 Sep 2019, Accepted 17 Dec 2019, Published online: 23 Jan 2020

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Thea Bjune, Thea Bjerkestrand Bøe, Stig Arne Kjellevold, Kristian Heldal & Sadollah Abedini. (2023) Hyperkalemia and the Use of New Potassium Binders a Single Center Experience from Vestfold Norway (The PotBind Study). International Journal of Nephrology and Renovascular Disease 16, pages 73-82.
Read now
Abiy Agiro, Jamie P Dwyer, Yemisi Oluwatosin & Pooja Desai. (2023) Medical Costs in Patients with Hyperkalemia on Long-Term Sodium Zirconium Cyclosilicate Therapy: The RECOGNIZE II Study. ClinicoEconomics and Outcomes Research 15, pages 691-702.
Read now
Charles V. Pollack$suffix/text()$suffix/text(), Abiy Agiro, Fan Mu, Erin E. Cook, Esteban Lemus Wirtz, Joshua A. Young, Keith A. Betts & Yasmin G. Brahmbhatt. (2023) Impact on hospitalizations of long-term versus short-term therapy with sodium zirconium cyclosilicate during routine outpatient care of patients with hyperkalemia: the recognize I study. Expert Review of Pharmacoeconomics & Outcomes Research 23:2, pages 241-250.
Read now
Gates Colbert, Shilpa Sannapaneni & Edgar V Lerma. (2022) Clinical Efficacy, Safety, Tolerability, and Real-World Data of Patiromer for the Treatment of Hyperkalemia. Drug, Healthcare and Patient Safety 14, pages 87-96.
Read now
Nihar R. Desai, Paula J. Alvarez, Ladan Golestaneh, Steven D. Woods, Steven G. Coca & Christopher G. Rowan. (2021) Healthcare utilization and expenditures associated with hyperkalemia management: a retrospective study of Medicare Advantage patients. Journal of Medical Economics 24:1, pages 1025-1036.
Read now

Articles from other publishers (16)

Eleonora Riccio, Anna D’Ercole, Anna Sannino, Sarah Hamzeh, Oriana De Marco, Ivana Capuano, Pasquale Buonanno, Manuela Rizzo & Antonio Pisani. (2024) Real-world management of chronic and postprandial hyperkalemia in CKD patients treated with patiromer: a single-center retrospective study. Journal of Nephrology.
Crossref
Ailema Gonzalez-Ortiz, Catherine M. Clase, Alessandro Bosi, Edouard L. Fu, Beatriz E. Pérez-Guillé, Anne-Laure Faucon, Marie Evans, Carmine Zoccali & Juan-Jesús Carrero. (2024) Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project. Journal of Nephrology.
Crossref
Aneesh GuptaJennifer KammererImran ShaikKathakali G. MukherjeeJuliana OliveiraCharuhas Thakar. (2024) Evaluation of longer- vs short-term use of patiromer on health care resource utilization in the patiromer longer-term use evaluation (VALUE) study. Journal of Managed Care & Specialty Pharmacy 30:1, pages 52-60.
Crossref
Abiy Agiro, Amin AN, Erin E. Cook, Fan Mu, Jingyi Chen, Pooja Desai, Yemmie Oluwatosin & Charles V. PollackJr.Jr.. (2023) Real-World Modifications of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Hyperkalemia Initiating Sodium Zirconium Cyclosilicate Therapy: The OPTIMIZE I Study. Advances in Therapy 40:6, pages 2886-2901.
Crossref
Eiichiro Kanda, Naru Morita & Toshitaka Yajima. (2023) Impact of chronic potassium binder treatment on the clinical outcomes in patients with hyperkalemia: Results of a nationwide hospital-based cohort study. Frontiers in Physiology 14.
Crossref
Shardool Patel, Derek Pinnell, Joshua Qualls, Anitha Rathod, Wei Chen, Sylvie Boutin, Steven D. Woods, Csaba P. Kovesdy, Navdeep TangriBrian C. Sauer. (2023) Assessing patiromer utilization and associated serum potassium changes in US veterans with prior sodium polystyrene sulfonate exposure. Medicine 102:9, pages e33134.
Crossref
Ruixue Tian, Rongshan Li & Xiaoshuang Zhou. (2023) Recent Progresses in Non-Dialysis Chronic Kidney Disease Patients with Hyperkalemia: Outcomes and Therapeutic Strategies. Medicina 59:2, pages 353.
Crossref
Derek Pinnell, Shardool Patel, Joshua Qualls, Wei Chen, Anitha Rathod, Steven D. Woods, Sylvie Boutin, Csaba P. Kovesdy, Navdeep TangriBrian C. Sauer. (2022) Real-world evaluation of patiromer utilization and its effects on serum potassium in veterans with end stage kidney disease. Medicine 101:50, pages e32367.
Crossref
Pietro Scicchitano, Massimo Iacoviello, Francesco Massari, Micaela De Palo, Pasquale Caldarola, Antonia Mannarini, Andrea Passantino, Marco Matteo Ciccone & Michele Magnesa. (2022) Optimizing Therapies in Heart Failure: The Role of Potassium Binders. Biomedicines 10:7, pages 1721.
Crossref
Steven Fishbane, David M. Charytan, Glenn M. Chertow, Martin Ford, Csaba P. Kovesdy, Pablo E. Pergola, Carol Pollock & Bruce Spinowitz. (2022) Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting. Journal of Renal Nutrition 32:4, pages e1-e14.
Crossref
Barbara Fischer, Andreas Serra & Harry Telser. (2022) Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective. Advances in Therapy 39:6, pages 2717-2730.
Crossref
Faissal A. M. Shaheen, Aurelie Meunier, Abdulaziz Altowaijri, Talal Al Faadhel, Hana Al-Abdulkarim, Adnan AlGabash & Lefteris Floros. (2022) Cost Consequence Analysis of the Management of Hyperkalemia by Patiromer and Optimization of Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Chronic Kidney Disease Patients in Saudi Arabia. Saudi Journal of Kidney Diseases and Transplantation 33:Suppl 1, pages S39-S52.
Crossref
Andrew S. Terker & David H. Ellison. (2022) Pathophysiology, Evaluation, and Treatment of Hyperkalemia. Nephrology Self-Assessment Program 20:2, pages 117-129.
Crossref
Mohammad Atiquzzaman, Peter Birks, Micheli Bevilacqua, Michelle M. Y. Wong, Yuyan Zheng, Ognjenka Djurdjev & Adeera Levin. (2022) Prescription Pattern of Cation Exchange Resins and Their Efficacy in Treating Chronic Hyperkalemia Among Patients With Chronic Kidney Diseases: Findings From a Population-Based Analysis in British Columbia, Canada. Canadian Journal of Kidney Health and Disease 9, pages 205435812211371.
Crossref
Patrick Rossignol, Lea David, Christine Chan, Ansgar Conrad & Matthew R. Weir. (2021) Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial Program. Drugs - Real World Outcomes 8:3, pages 315-323.
Crossref
Waleed Ali & George Bakris. (2020) Evolution of Patiromer Use: a Review. Current Cardiology Reports 22:9.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.